Mortality News and Research

RSS

Repurposing public health systems can provide near-to-real-time data on SARS-CoV-2

Existing public health monitoring systems in the UK, could improve understanding of the risk factors associated with severe COVID-19.

7 Jul 2020

Life beyond COVID seclusion: Seniors see challenges and change ahead

Months into the coronavirus pandemic, older adults are having a hard time envisioning their "new normal."

7 Jul 2020

Dutch trial of convalescent plasma in COVID-19 discontinued

Now, a recent trial published on the preprint server medRxiv* in July 2020 reports that a majority of hospitalized COVID-19 patients have a high titer of neutralizing antibodies, at the time of admission, within 10 days of symptomatic disease.

7 Jul 2020

Study results do not show benefit of proteomic analysis for detecting diabetic nephropathy

One of the consequences of diabetes mellitus, particularly if accompanied by high blood pressure (hypertension), can be a chronic kidney disease (diabetic nephropathy), which can lead to permanent failure of the kidneys (end-stage renal disease).

6 Jul 2020

COVID-19 risk halved when airplane middle seats empty, expert statistician says

As the coronavirus cases skyrocket, many countries have started to ease lockdown measures to save the ailing economy. Restaurants, malls, recreational centers, and transportation are slowly returning to normal operations. However, one of the most heavily impacted sectors amid the pandemic is the aviation industry.

6 Jul 2020

COVID-19 complications may be associated with von Willebrand factor in the blood

Anna Aksenova, a senior research associate at the Laboratory of Amyloid Biology at St Petersburg University, has advanced a hypothesis that the severe course of COVID-19 may be associated with von Willebrand factor.

6 Jul 2020

Clemson researcher receives DOD grant to explore cellular underpinnings of developmental disorder

College of Science associate professor and researcher David Feliciano has received a $667,000 grant from the Department of Defense to explore the cellular underpinnings of Tuberous Sclerosis Complex (TSC), a developmental disorder characterized by the growth of benign tumors throughout the body, most notably in the brain.

6 Jul 2020

One-fifth of Georgian Londoners contracted syphilis in their mid-30s

250 years ago, over one-fifth of Londoners had contracted syphilis by their 35th birthday, historians have calculated.

6 Jul 2020

Novel cell-based approach used to reverse age-related impairments in animal model

Elderly people are more prone to infectious diseases as the function of their immune system continuously declines with progression of age.

6 Jul 2020

Sweden’s controversial decision increased COVID-19 deaths

Sweden's controversial decision not to lock down during COVID-19 produced more deaths and greater healthcare demand than seen in countries with earlier, more stringent interventions, a new analysis finds.

6 Jul 2020

Research suggests protective effect of influenza vaccine against COVID-19 severity and mortality

A new study involving over 92,000 patients with COVID-19 in Brazil shows that the odds of severe disease, ventilatory support requirement, and death are reduced with a recent trivalent flu vaccine. This seems to indicate that these vaccines should be used as widely as possible to reduce the risk of severe COVID-19, especially among high-risk groups. The study is published on the preprint server medRxiv* in June 2020.

5 Jul 2020

High population density in India associated with spread of COVID-19

Indian health experts say the findings of a US study — which suggest that population density is unrelated to COVID-19 infection rates — to be completely contradictory to their experience of dealing with the pandemic in India, a country with 1.3 billion people.

3 Jul 2020

Official U.S.tallies likely undercount COVID-19 deaths

The United States is the hardest-hit nation amid the coronavirus pandemic, with its case toll has topping 2.73 million. The death toll in the official tally has reached 128,742. Now, a new study published in the journal JAMA Internal Medicine suggests that the coronavirus disease (COVID-19) deaths between March and May in the country were likely 28 percent higher than the official tally reported.

3 Jul 2020

Markers of vascular damage in COVID-19

A new study by researchers at Yale University and published on the preprint server medRxiv reports on the plasma levels of biomolecules that reflect vascular damage in COVID-19.

2 Jul 2020

Effectiveness of NPI's in COVID-19 - conclusions are predictable, NPI's work

Now, a new study published on the preprint server medRxiv* looks at how the effects of these NPIs can be quantified in order to keep the public health response to COVID-19 at an adequate level. While NPIs are known to reduce the peak of the infections, in general, the researchers wanted to quantify different components separately.

2 Jul 2020

More evidence on vitamin D deficiency and death rates from COVID-19

Physicians at the Complete Med Care clinic in Dallas, Texas, have conducted a study showing that the prevalence of severe vitamin D deficiency is strongly correlated with coronavirus disease 2019 (COVID-19) mortality rate in European countries.

2 Jul 2020

Study shows connection between timing of SNAP benefits and childhood injuries

A new study published recently in "BMC Pediatrics" shows a connection between the time of the month when low-income families receive their Supplemental Nutrition Assistance Program (SNAP) benefits and the number of emergency room visits due to injuries to children from those families.

2 Jul 2020

Study identifies a promising way to delay the onset of Alzheimer's disease

Currently we are facing a dementia epidemic, estimations showing that by 2050 approximately 131 million people will be affected. Every 7 seconds a patient is diagnosed worldwide.

2 Jul 2020

Novel microbiome-based diagnostic tool can identify liver fibrosis, cirrhosis

Chronic liver disease represents a major global public health problem affecting an estimated 844 million people, according to the World Health Organization. It is among the top causes of mortality in Australia, the UK and the United States.

2 Jul 2020

Repurposed drug for acute lung injury in COVID-19

Now, a new study addresses the possible use of an FDA-approved monoclonal antibody, called fostamatinib, a spleen tyrosine kinase inhibitor (SYK), to reduce the levels of mucin-1, a molecule associated with acute lung injury and acute respiratory distress syndrome (ARDS). People who have severe COVID-19 disease may develop ARDS.

2 Jul 2020